IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Titel:
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Auteur:
Bagot, Martine Porcu, Pierluigi Marie-Cardine, Anne Battistella, Maxime William, Basem M Vermeer, Maarten Whittaker, Sean Rotolo, Federico Ram-Wolff, Caroline Khodadoust, Michael S Bensussan, Armand Paturel, Carine Bonnafous, Cecile Sicard, Helene Azim Jr, Hatem A Kim, Youn H